InsidersTradesSigma
Follow the Kintor Pharmaceutical Ltd. - B stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, Kintor Pharmaceutical Ltd. - B has recorded 21 public disclosures. Market capitalisation: €773.7m. The latest transaction was disclosed on 21 July 2026 (Purchase). Among the most active insiders: Tong Youzhi. Every trade is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€7m
19 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,046 of 29,064 companies
13.4
score / 100
Value9
Quality17
FCF yld-21%
Earn yld-25%
EV/EBITDA·
ROE-118%
Gross mgn25%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 July 2026
Declarations21 total
145,000 shares@ HK$1.7130.032% mcap0.4% of flowShareXHKGHKEX:DA20260721E00089
250,000 shares@ HK$2.0620.059% mcap0.9% of flowShareXHKGHKEX:DA20260626E00073
75,000 shares@ HK$2.4360.0021% mcap0.3% of flowShareXHKGHKEX:DA20260611E00155
125,000 shares@ HK$2.5180.0036% mcap0.5% of flowShareXHKGHKEX:DA20260608E00336
50,000 shares@ HK$2.600.0015% mcap0.2% of flowShareXHKGHKEX:DA20260608E00319
190,000 shares@ HK$2.230.0048% mcap0.7% of flowShareXHKGHKEX:DA20260528E00212
110,000 shares@ HK$2.4750.0031% mcap0.5% of flowShareXHKGHKEX:DA20260528E00199
42,000 shares@ HK$2.330.0011% mcap0.2% of flowShareXHKGHKEX:DA20260528E00204
38,000 shares@ HK$2.640.0011% mcap0.2% of flowShareXHKGHKEX:DA20260522E00299
70,000 shares@ HK$2.740.18% mcap27.1% of flowShareXHKGHKEX:DA20260520E00152
170,000 shares@ HK$2.800.45% mcap67.6% of flowShareXHKGHKEX:DA20260519E00135
80,000 shares@ HK$2.870.023% mcap0.4% of flowShareXHKGHKEX:DA20260511E00237
28,000 shares@ HK$2.6360.0075% mcap0.1% of flowShareXHKGHKEX:DA20260427E00032
48,000 shares@ HK$2.7180.013% mcap0.2% of flowShareXHKGHKEX:DA20260422E00263
10,000 shares@ HK$2.7470.0028% mcap0.0% of flowShareXHKGHKEX:DA20260420E00094
290,000 shares@ HK$2.7550.080% mcap1.3% of flowShareXHKGHKEX:DA20260417E00334
50,000 shares@ HK$2.640.0016% mcap7.5% of flowShareXHKGHKEX:DA20260410E00214
65,000 shares@ HK$2.700.0021% mcap10.1% of flowShareXHKGHKEX:DA20260409E00109
71,500 shares@ HK$2.5940.0022% mcap10.7% of flowShareXHKGHKEX:DA20260407E00049
1,250,000 sharesShareXHKGHKEX:DA20260401E00085
21 of 21 declarations
关于 Kintor Pharmaceutical Ltd. - B
Kintor Pharmaceutical Ltd. 是一家生物制药公司，专注于开发治疗严重疾病的创新疗法。该公司在香港证券交易所上市。